FDA.reportPublic FDA data

ruxolitinib 15 MG Oral Tablet [Jakafi]

RxCUI
1193345
RxNorm name
ruxolitinib 15 MG Oral Tablet [Jakafi]
Display name
ruxolitinib 15 MG Oral Tablet [Jakafi]
Full name
ruxolitinib 15 MG Oral Tablet [Jakafi]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:27

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
f1c82580-87ae-11e0-bc84-0002a5d5c51bruxolitinib 15 MG Oral Tablet [Jakafi]SBD40These highlights do not include all the information needed to use JAKAFI/JAKAFI XR safely and effectively. See full prescribing information for JAKAFI/JAKAFI XR. JAKAFI ® (ruxolitinib) tablets, for oral use JAKAFI XR™ (ruxolitinib) extended-release tablets, for oral use Initial U.S. Approval: 201120260501
f1c82580-87ae-11e0-bc84-0002a5d5c51bJakafi 15 MG Oral TabletSY40These highlights do not include all the information needed to use JAKAFI/JAKAFI XR safely and effectively. See full prescribing information for JAKAFI/JAKAFI XR. JAKAFI ® (ruxolitinib) tablets, for oral use JAKAFI XR™ (ruxolitinib) extended-release tablets, for oral use Initial U.S. Approval: 201120260501
f1c82580-87ae-11e0-bc84-0002a5d5c51bJakafi 15 MG Oral TabletPSN40These highlights do not include all the information needed to use JAKAFI/JAKAFI XR safely and effectively. See full prescribing information for JAKAFI/JAKAFI XR. JAKAFI ® (ruxolitinib) tablets, for oral use JAKAFI XR™ (ruxolitinib) extended-release tablets, for oral use Initial U.S. Approval: 201120260501